Daiichi Sankyo Co., Ltd.
|Daiichi Sankyo Co., Ltd. Patent applications|
|Patent application number||Title||Published|
|20160024161||NOVEL BINDING PROTEINS FOR PCSK9 - The present disclosure relates to novel lipocalin muteins which bind to PCSK9. The disclosure also provides corresponding nucleic acid molecules encoding lipocalin muteins and methods for producing lipocalin muteins as well as their encoding nucleic acid molecules.||01-28-2016|
|20130280282||DR5 LIGAND DRUG CONJUGATES - Ligand Drug Conjugates are provided having a DR5 binding moiety attached via linking groups and/or spacers to a therapeutic agent that are effective in treatment of various cancers.||10-24-2013|
|20130197072||METHOD FOR MANUFACTURING NEURAMINIC ACID DERIVATIVES - Methods for manufacturing neuraminic acid compounds and synthetic intermediates of neuraminic acid compounds, including a method for manufacturing a compound represented by||08-01-2013|
|20110070248||DR5 LIGAND DRUG CONJUGATES - Ligand Drug Conjugates are provided having a DR5 binding moiety attached via linking groups and/or spacers to a therapeutic agent and are effective in treatment of various cancers.||03-24-2011|
Patent applications by Daiichi Sankyo Co., Ltd.